aHUS News

aHUS News

aHUS News is a digital resource designed to keep the atypical hemolytic uremic syndrome (aHUS) community updated with the latest news and insights. It also features personal stories and viewpoints from our patient and caregiver contributors. Every article on aHUS News is created by our dedicated team of writers and editors. From time to time, we invite external experts to share their knowledge through interviews and Q&A sessions. Our publishing team consists of science writers and editors, many of whom hold PhDs in life sciences, along with experienced journalists and columnists who are part of the AADC community. Together, they strive to ensure that all content on aHUS News is accurate, relevant, informative, and easy to understand for our readers.

National
English
Online/Digital

Outlet metrics

Domain Authority
24
Ranking

Global

#4878230

United States

#1407858

Category

N/A

Traffic sources
Monthly visitors

Articles

  • 1 week ago | ahusnews.com | Marisa Wexler

    A woman in Italy developed atypical hemolytic uremic syndrome (aHUS) as a result of a blood cancer, which resolved after the cancer was brought into remission, a case study shows. The report, " Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab ," was published in Haematologica.

  • 3 weeks ago | ahusnews.com | Marisa Wexler

    Inflammation of the pancreas, known as pancreatitis, can occur alongside the rare disease atypical hemolytic uremic syndrome (aHUS) - as a team of researchers from China highlighted in a new report outlining the case of a young woman found to have both conditions. The woman sought medical attention due to gastrointestinal issues, including abdominal pain and nausea.

  • 1 month ago | ahusnews.com | Marisa Wexler

    Soliris (eculizumab) helped control atypical hemolytic uremic syndrome (aHUS) in a patient whose symptoms included seizures and signs of neurological damage, according to a case report.

  • 1 month ago | ahusnews.com | Margarida Maia

    Soliris (eculizumab) is safe and effective for treating children with various types of hemolytic uremic syndrome (HUS), including atypical HUS (aHUS), according to a real-world study involving pediatric patients in Israel. In fact, more than half of the children with aHUS given Soliris in the study achieved a complete response, meaning they showed sustained normalization of blood parameters and kidney function improvements.

  • 1 month ago | ahusnews.com | Andrea Lobo

    Plasma exchange therapy successfully managed atypical hemolytic uremic syndrome (aHUS) triggered by pancreas inflammation in a 72-year-old man, according to a case report from China. However, discontinuation of plasma exchange and a transition to hemodialysis - a treatment used to remove waste and excessive fluid from the blood when the kidneys are not functioning normally - led the patient to develop chronic kidney failure, per the report.

aHUS News journalists

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations